The University of Oslo sensor software spinout has started trading on the Merkur Market, part of the Oslo Stock Exchange.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Incubated by Vision Institute, the retinal disease gene therapy developer has secured $52.8m in a round co-led by UPMC Enterprises.

QUB spinout ProAxsis has been fully acquired by NetScientific, which previously backed the company’s sole funding round in 2014.

The telecommunications company's newly formed Telefónica Tech Ventures will carry over nine portfolio companies and invest in 15 over the next three years.

The retinal disease gene therapy developer has secured $52.8m in a round co-led by UPMC Enterprises that will go toward further developing its drug pipeline.

Rheinische Post Mediengruppe has taken part in a $2.3m round for the podcast marketing platform a year after it was founded.

Nine companies will participate in the internet company’s three-month accelerator programme, which is set to launch next month.

The mobile network operator's T-Mobile Ventures unit is being managed by Touchdown Ventures and will target 5G-related technologies.

Lanxness contributed to the third fund to be closed by venture firm UVC Partners which will back business-to-business software, industrial and mobility technology startups.